These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23227158)

  • 21. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
    Hanazaki K; Wakabayashi M; Sodeyama H; Kajikawa S; Amano J
    Hepatogastroenterology; 1999; 46(30):3201-7. PubMed ID: 10626186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; Polak WG; Verhoef C; Eskens FA; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN
    Dig Surg; 2012; 29(6):522-8. PubMed ID: 23548745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
    Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study.
    Zhao X; Luo J; Li B; Liu S; Li D
    PLoS One; 2015; 10(1):e0116909. PubMed ID: 25602444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.
    Lee CW; Yu MC; Lin G; Chiu JC; Chiang MH; Sung CM; Hsieh YC; Kuo T; Lin CY; Tsai HI
    World J Surg Oncol; 2020 Jun; 18(1):121. PubMed ID: 32493393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.
    Cheng Z; Yang P; Qu S; Zhou J; Yang J; Yang X; Xia Y; Li J; Wang K; Yan Z; Wu D; Zhang B; Hüser N; Shen F
    HPB (Oxford); 2015 May; 17(5):422-7. PubMed ID: 25421805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy.
    Haruyama Y; Yorita K; Yamaguchi T; Kitajima S; Amano J; Ohtomo T; Ohno A; Kondo K; Kataoka H
    Int J Cancer; 2015 Oct; 137(7):1643-51. PubMed ID: 25784484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy.
    Wu Y; Tu C; Shao C
    BMC Surg; 2021 Apr; 21(1):178. PubMed ID: 33794850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
    Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
    Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.